197
Views
24
CrossRef citations to date
0
Altmetric
Review

Outlining novel cellular adjuvant products for therapeutic vaccines against cancer

&
Pages 1207-1220 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rajesh K Sharma, Zinal S Chheda, Venkatakrishna R Jala & Bodduluri Haribabu. (2015) Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy. Expert Review of Vaccines 14:4, pages 537-549.
Read now
Timothy Brauns, Pierre Leblanc, Jeffrey A Gelfand & Mark Poznanski. (2015) Could mycobacterial Hsp70-containing fusion protein lead the way to an affordable therapeutic cancer vaccine?. Expert Review of Vaccines 14:3, pages 435-446.
Read now
Christopher B Fox & Jean Haensler. (2013) An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants. Expert Review of Vaccines 12:7, pages 747-758.
Read now

Articles from other publishers (21)

Maryam Golshani, Mona Amani, Fatemeh Amirzadeh, Elahe Nazeri, Seyed Davar Siadat, Mehdi Nejati-Moheimani, Amin Arsang & Saeid Bouzari. (2020) Evaluation of Poly(I:C) and combination of CpG ODN plus Montanide ISA adjuvants to enhance the efficacy of outer membrane vesicles as an acellular vaccine against Brucella melitensis infection in mice. International Immunopharmacology 84, pages 106573.
Crossref
Md. Asadujjaman, Kwan Hyung Cho, Dong-Jin Jang, Joo-Eun Kim & Jun-Pil Jee. (2020) Nanotechnology in the arena of cancer immunotherapy. Archives of Pharmacal Research 43:1, pages 58-79.
Crossref
Karim Vermaelen. (2019) Vaccine Strategies to Improve Anti-cancer Cellular Immune Responses. Frontiers in Immunology 10.
Crossref
Minyoung Kwak, Norma E. Farrow, April K. S. Salama, Paul J. Mosca, Brent A. Hanks, Craig L. Slingluff & Georgia M. Beasley. (2018) Updates in adjuvant systemic therapy for melanoma. Journal of Surgical Oncology 119:2, pages 222-231.
Crossref
Maryam Golshani, Mona Amani, Seyed Davar Siadat, Mehdi Nejati-Moheimani, Amin Arsang & Saeid Bouzari. (2018) Comparison of the protective immunity elicited by a Brucella cocktail protein vaccine (rL7/L12+rTOmp31+rSOmp2b) in two different adjuvant formulations in BALB/c mice. Molecular Immunology 103, pages 306-311.
Crossref
Tatyana A. Kuznetsova, Elena V. Persiyanova, Svetlana P. Ermakova, Maxim Yu. Khotimchenko & Natalya N. Besednova. (2018) The Sulfated Polysaccharides of Brown Algae and Products of Their Enzymatic Transformation as Potential Vaccine Adjuvants. Natural Product Communications 13:8, pages 1934578X1801300.
Crossref
Jixue Wang, Shengxian Li, Yuping Han, Jingjing Guan, Shirley Chung, Chunxi Wang & Di Li. (2018) Poly(Ethylene Glycol)–Polylactide Micelles for Cancer Therapy. Frontiers in Pharmacology 9.
Crossref
Elizabeth Reznik, Andrew W. Smith, Shoshana Taube, Justin Mann, Menachem Z. Yondorf, Bhupesh Parashar & A. Gabriella Wernicke. (2018) Radiation and Immunotherapy in High-grade Gliomas. American Journal of Clinical Oncology 41:2, pages 197-212.
Crossref
Liyan Jiang, Zhipu Yu, Yu Lin, Liran Cui, Shujuan Yao, Liyan Lv & Jicheng Liu. (2018) Low-molecular-weight polysaccharides from Agaricus�blazei Murrill modulate the Th1 response in cancer immunity. Oncology Letters.
Crossref
Vito Pistoia, Ignazia Prigione & Lizzia Raffaghello. 2018. Immunotherapy for Pediatric Malignancies. Immunotherapy for Pediatric Malignancies 243 257 .
T. Barclay & N. Petrovsky. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development 127 147 .
Cristina Maria de Barros, Emad Ibrahim Wafa, Khanidtha Chitphet, Kawther Ahmed, Sean M. Geary & Aliasger K. Salem. 2017. Vaccine Adjuvants. Vaccine Adjuvants 201 213 .
Chung-Hsiung Huang, Chiung-Yi Huang, Chih-Ping Cheng, Shih-Hsiung Dai, Hsin-Wei Chen, Chih-Hsiang Leng, Pele Chong, Shih-Jen Liu & Ming-Hsi Huang. (2016) Degradable emulsion as vaccine adjuvant reshapes antigen-specific immunity and thereby ameliorates vaccine efficacy. Scientific Reports 6:1.
Crossref
Daniele D'Alonzo, Manuela Cipolletti, Giulia Tarantino, Marcello Ziaco, Giuseppina Pieretti, Alfonso Iadonisi, Giovanni Palumbo, Alberto Alfano, Mariateresa Giuliano, Mario De Rosa, Chiara Schiraldi, Marcella Cammarota, Michelangelo Parrilli, Emiliano Bedini & Maria M. Corsaro. (2016) A Semisynthetic Approach to New Immunoadjuvant Candidates: Site-Selective Chemical Manipulation of Escherichia coli Monophosphoryl Lipid A . Chemistry - A European Journal 22:31, pages 11053-11063.
Crossref
Afshin Hassani-Mehraban, Sjoerd Creutzburg, Luc van Heereveld & Richard Kormelink. (2015) Feasibility of Cowpea chlorotic mottle virus-like particles as scaffold for epitope presentations. BMC Biotechnology 15:1.
Crossref
Fanny Coumes, Chiung-Yi Huang, Chung-Hsiung Huang, Jean Coudane, Dominique Domurado, Suming Li, Vincent Darcos & Ming-Hsi Huang. (2015) Design and Development of Immunomodulatory Antigen Delivery Systems Based on Peptide/PEG–PLA Conjugate for Tuning Immunity. Biomacromolecules 16:11, pages 3666-3673.
Crossref
Catherine Gérard, Nathalie Baudson, Thierry Ory, Lawrence Segal & Jamila Louahed. (2015) A Comprehensive Preclinical Model Evaluating the Recombinant PRAME Antigen Combined With the AS15 Immunostimulant to Fight Against PRAME-expressing Tumors. Journal of Immunotherapy 38:8, pages 311-320.
Crossref
Eric Destexhe, Emilie Grosdidier, Nathalie Baudson, Roy Forster, Catherine Gerard, Nathalie Garçon & Lawrence Segal. (2014) Non‐clinical safety evaluation of single and repeated intramuscular administrations of MAGE‐A3 Cancer Immunotherapeutic in rabbits and cynomolgus monkeys. Journal of Applied Toxicology 35:7, pages 717-728.
Crossref
Susan N. Thomas, Efthymia Vokali, Amanda W. Lund, Jeffrey A. Hubbell & Melody A. Swartz. (2014) Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Biomaterials 35:2, pages 814-824.
Crossref
. (2013) Current World Literature. Current Opinion in Oncology 25:3, pages 325-337.
Crossref
Joseph G. Altin. 2012. Innovation in Vaccinology. Innovation in Vaccinology 135 178 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.